166 related articles for article (PubMed ID: 10880734)
1. Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses.
Fridkis-Hareli M; Rosloniec EF; Fugger L; Strominger JL
Hum Immunol; 2000 Jul; 61(7):640-50. PubMed ID: 10880734
[TBL] [Abstract][Full Text] [Related]
2. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH
Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
Rosloniec EF; Whittington KB; Zaller DM; Kang AH
J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
[TBL] [Abstract][Full Text] [Related]
4. Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules.
Fridkis-Hareli M; Neveu JM; Robinson RA; Lane WS; Gauthier L; Wucherpfennig KW; Sela M; Strominger JL
J Immunol; 1999 Apr; 162(8):4697-704. PubMed ID: 10202010
[TBL] [Abstract][Full Text] [Related]
5. Synthetic amino acid copolymers that bind to HLA-DR proteins and inhibit type II collagen-reactive T cell clones.
Fridkis-Hareli M; Rosloniec EF; Fugger L; Strominger JL
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12528-31. PubMed ID: 9770519
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
7. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK
Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003
[TBL] [Abstract][Full Text] [Related]
8. Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice.
Andersson EC; Hansen BE; Jacobsen H; Madsen LS; Andersen CB; Engberg J; Rothbard JB; McDevitt GS; Malmström V; Holmdahl R; Svejgaard A; Fugger L
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7574-9. PubMed ID: 9636191
[TBL] [Abstract][Full Text] [Related]
9. Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background.
Knapp B; Fischer G; Van Hemelen D; Fae I; Maillere B; Ebner C; Schreiner W; Bohle B; Jahn-Schmid B
BMC Immunol; 2012 Aug; 13():43. PubMed ID: 22871092
[TBL] [Abstract][Full Text] [Related]
10. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.
Rosloniec EF; Brand DD; Myers LK; Esaki Y; Whittington KB; Zaller DM; Woods A; Stuart JM; Kang AH
J Immunol; 1998 Mar; 160(6):2573-8. PubMed ID: 9510154
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte responses to DR1/4 restricted peptides in rheumatoid arthritis.
Skinner MA; Watson L; Geursen A; Tan PL
Ann Rheum Dis; 1994 Mar; 53(3):171-7. PubMed ID: 8154934
[TBL] [Abstract][Full Text] [Related]
12. T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles.
Cope AP; Patel SD; Hall F; Congia M; Hubers HA; Verheijden GF; Boots AM; Menon R; Trucco M; Rijnders AW; Sønderstrup G
Arthritis Rheum; 1999 Jul; 42(7):1497-507. PubMed ID: 10403279
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte responses to DR4/1-restricted peptides in rheumatoid arthritis. The immunodominant T cell epitope on the 19-kd Mycobacterium tuberculosis protein.
Tan PL; Farmiloe S; Young J; Watson JD; Skinner MA
Arthritis Rheum; 1992 Dec; 35(12):1419-26. PubMed ID: 1472121
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides.
Li X; Li R; Li Z
Tissue Antigens; 2006 Jan; 67(1):45-52. PubMed ID: 16451200
[TBL] [Abstract][Full Text] [Related]
15. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model.
von Delwig A; Altmann DM; Isaacs JD; Harding CV; Holmdahl R; McKie N; Robinson JH
Arthritis Rheum; 2006 Feb; 54(2):482-91. PubMed ID: 16447222
[TBL] [Abstract][Full Text] [Related]
16. Influenza virus haemagglutinin-derived peptides inhibit T-cell activation induced by HLA-DR4/1 specific peptides in rheumatoid arthritis.
Li X; Li R; Li Z
Clin Exp Rheumatol; 2006; 24(2):148-54. PubMed ID: 16762149
[TBL] [Abstract][Full Text] [Related]
17. Peptide motif analysis predicts alphaviruses as triggers for rheumatoid arthritis.
Hogeboom C
Mol Immunol; 2015 Dec; 68(2 Pt B):465-75. PubMed ID: 26476978
[TBL] [Abstract][Full Text] [Related]
18. Effects of type II collagen epitope carbamylation and citrullination in human leucocyte antigen (HLA)-DR4(+) monozygotic twins discordant for rheumatoid arthritis.
De Santis M; Ceribelli A; Cavaciocchi F; Generali E; Massarotti M; Isailovic N; Crotti C; Scherer HU; Montecucco C; Selmi C
Clin Exp Immunol; 2016 Sep; 185(3):309-19. PubMed ID: 27314557
[TBL] [Abstract][Full Text] [Related]
19. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR1 and DRw6 association in DR4-negative rheumatoid arthritis patients.
Lang B; Melchers I; Urlacher A; Tanzi-Fetta RF; Kohlbrenner S; Tongio MM; Peter HH
Rheumatol Int; 1990; 10(4):171-5. PubMed ID: 2259843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
